STEEPLES ADRIAN 4
4 · QUAKER CHEMICAL CORP · Filed Aug 13, 2020
Insider Transaction Report
Form 4
STEEPLES ADRIAN
VP & Managing Director - A/P
Transactions
- Exercise/Conversion
Common Stock
2020-08-12$134.60/sh+2,188$294,505→ 8,663 total - Sale
Common Stock
2020-08-12$200.64/sh−188$37,720→ 8,475 total - Sale
Common Stock
2020-08-12$201.65/sh−1,300$262,145→ 7,175 total - Sale
Common Stock
2020-08-12$202.74/sh−700$141,918→ 6,475 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-08-12−2,188→ 0 totalExercise: $134.60Exp: 2024-02-27→ Common Stock (2,188 underlying)
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $200.13 to $200.80, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $201.20 to $202.14, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.57 to $202.93, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The options for this grant vested in three annual installments: 730 shares on February 27, 2018; 729 shares on February 27, 2019; and 729 shares on February 27, 2020.